Award
Purchase Order #75F40126P00309
Agilent Technologies Awarded Contract for ICP-QQQ Analytical Equipment
Buyer
Food and Drug Administration
Award Amount
$283,395.14
Ceiling
$336,131.78
Awarded
September 10, 2026
Period of Performance
Sep 10, 2026 – Dec 09, 2026
Identifier
75F40126P00309
NAICS
334516
This contract award represents a purchase order for the acquisition of advanced scientific instrumentation. The recipient, Agilent Technologies Inc, a leading global company specializing in analytical measurement solutions, is contracted to provide an Agilent 9500 ICP-QQQ Bundle. This sophisticated equipment is used for precise chemical analysis and is critical for laboratory and research applications within the government agency. The contract highlights the agency's commitment to maintaining cutting-edge analytical capabilities, impacting scientific research and regulatory compliance. The scope of work includes the delivery and installation of the bundled ICP-QQQ system at a facility in Wilmington, Delaware, ensuring state-of-the-art operational functionality. Awarded through a defined procurement process, this purchase order signals a targeted acquisition to fulfill specific analytical needs without a competitive bidding element disclosed. The contract spans a defined term with performance expected within a few months, while options may extend service and support over a longer duration, underscoring an investment in long-term technological advancement.
Description
"EO 14398" AGILENT 9500 ICP-QQQ BUNDLE